
Legend Biotech Announces Q1 2025 Financial Results and Key Developments
Legend Biotech Reports Strong First Quarter 2025 Performance and Strategic Milestones as CARVYKTI® Continues to Lead in Multiple Myeloma Legend Biotech Corporation, a global frontrunner in the field of cell therapy, has reported its financial results for the first quarter…